Quick Answer
Zura Bio Ltd reported Total Assets of $113.95 million for the year ending 2025.
- Zura Bio Ltd showed a decrease of -36.5% in Total Assets from 2024 to 2025.
- This data is from Zura Bio Ltd's annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $95.6 thousand | Q2 2021: $164.8 thousand | Q3 2021: $140.91 million | Q1 2022: $140.25 million | Q2 2022: $140.03 million | Q3 2022: $140.48 million | Q1 2023: $44.39 million | Q2 2023: $113.33 million | Q3 2023: $104.59 million | Q1 2024: $90.48 million | Q2 2024: $189.50 million | Q3 2024: $189.07 million | Q1 2025: $172.50 million | Q2 2025: $157.81 million | Q3 2025: $143.94 million.
- Over the full 5 years of available data (2021 to 2025), Zura Bio Ltd's Total Assets has declined by 18.9%.
- Historical annual values: Fiscal year 2025: $113.95 million | Fiscal year 2024: $179.53 million | Fiscal year 2023: $100.84 million | Fiscal year 2022: $5.26 million | Fiscal year 2021: $140.55 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: